Amgen Faces Bearish Sentiment from Financial Giants

Bearish sentiment looms over Amgen as financial behemoths navigate through unusual trades analysis. With 63% exhibiting bearish tendencies, traders are eyeing a price range from $290 to $340.

Date: 25-03-2025

AI Rating: 4

Market Sentiment Analysis
Today's analysis reveals a significant bearish trend among traders concerning Amgen. Out of 19 unusual trades identified, a whopping 63% leaned towards bearish sentiment, while only 26% were bullish.

In terms of specific options data, Put Options became more prevalent, as evidenced by 14 puts valued at $762,532 and a mere 5 calls valued at $755,304. This discrepancy suggests a lack of confidence in Amgen's ability to maintain or increase its stock price in the short term.

In addition, Expected Price Movements indicate whales are targeting a price range from $290.0 to $340.0. This is a notable range that reflects investor caution. The recent trading volume for Amgen stands at 1,441,651, with the price currently down by -3.31%, resting at $303.98. Such information not only reflects current market conditions but could inhibit trading interest negatively.

Expert Opinions on Amgen
A market expert from B of A Securities has issued an Underperform rating for Amgen, confirming this pessimistic outlook with a target price as low as $294.0. This analysis indicates pushing towards the lower threshold of the expected price range.

RSI Indicators and Upcoming Events
The RSI indicators show that the stock may be approaching an oversold condition; however, this can also represent prevailing negative sentiment among institutional traders. The stock's earnings announcement is anticipated in 37 days, a critical point that may impact pricing significantly depending on performance expectations.

Overall, the options activity regarding Amgen suggests that investors are leaning toward bearish sentiment, driven by current market factors and expert opinions.

Stocks: AMGN